{"id":"https://openalex.org/W2762425137","doi":"https://doi.org/10.1177/1060028017736539","title":"The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia","display_name":"The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia","publication_year":2017,"publication_date":"2017-10-12","ids":{"openalex":"https://openalex.org/W2762425137","doi":"https://doi.org/10.1177/1060028017736539","mag":"2762425137","pmid":"https://pubmed.ncbi.nlm.nih.gov/29025266"},"language":"en","primary_location":{"id":"doi:10.1177/1060028017736539","doi":"https://doi.org/10.1177/1060028017736539","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1060028017736539","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006133411","display_name":"Troy Z. Horvat","orcid":"https://orcid.org/0000-0003-4756-8157","observed_orcids":["https://orcid.org/0000-0003-4756-8157"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Troy Z. Horvat","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023474566","display_name":"Amanda N. Seddon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285301757","display_name":"Rush University Medical Center","ror":"https://ror.org/01j7c0b24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285301757"]},{"id":"https://openalex.org/I128902783","display_name":"Midwestern University","ror":"https://ror.org/046yatd98","country_code":"US","type":"education","lineage":["https://openalex.org/I128902783"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda N. Seddon","raw_affiliation_strings":["Midwestern University Chicago College of Pharmacy, Downers Grove, IL, USA","Rush University Medical Center, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Midwestern University Chicago College of Pharmacy, Downers Grove, IL, USA","institution_ids":["https://openalex.org/I128902783"]},{"raw_affiliation_string":"Rush University Medical Center, Chicago, IL, USA","institution_ids":["https://openalex.org/I1285301757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037814265","display_name":"Adebayo Ogunniyi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adebayo Ogunniyi","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071975128","display_name":"Amber C. King","orcid":"https://orcid.org/0000-0002-4333-9624","observed_orcids":["https://orcid.org/0000-0002-4333-9624"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amber C. King","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002443582","display_name":"Larry W. Buie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larry W. Buie","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022370459","display_name":"Ryan J. Daley","orcid":"https://orcid.org/0000-0002-8493-9271","observed_orcids":["https://orcid.org/0000-0002-8493-9271"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ryan J. Daley","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5022370459"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":0.1777,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.26726974,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"52","issue":"3","first_page":"268","last_page":"276"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9848999977111816,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/b-cell-acute-lymphoblastic-leukemia","display_name":"B-cell acute lymphoblastic leukemia","score":0.9779999852180481},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.8149999976158142},{"id":"https://openalex.org/keywords/adult-patients","display_name":"adult patients","score":0.5180000066757202},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.8309999704360962},{"id":"https://openalex.org/keywords/blinatumomab","display_name":"blinatumomab","score":0.9350000023841858},{"id":"https://openalex.org/keywords/inotuzumab","display_name":"inotuzumab","score":0.9279999732971191},{"id":"https://openalex.org/keywords/ofatumumab","display_name":"ofatumumab","score":0.9940000176429749},{"id":"https://openalex.org/keywords/obinutuzumab","display_name":"obinutuzumab","score":1.0},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.8450000286102295},{"id":"https://openalex.org/keywords/cd19-car-t-cell-therapy","display_name":"CD19 CAR T-cell therapy","score":0.8790000081062317},{"id":"https://openalex.org/keywords/relapsed-refractory-leukemia","display_name":"relapsed/refractory leukemia","score":0.8870000243186951},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5180000066757202},{"id":"https://openalex.org/keywords/treatment-sequencing","display_name":"treatment sequencing","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C2778020697","wikidata":"https://www.wikidata.org/wiki/Q410189","display_name":"Blinatumomab","level":4,"score":0.9608776569366455},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9036871194839478},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.6010526418685913},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5641723275184631},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.5313573479652405},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5183149576187134},{"id":"https://openalex.org/C2777607594","wikidata":"https://www.wikidata.org/wiki/Q389496","display_name":"Obinutuzumab","level":4,"score":0.5170079469680786},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5045417547225952},{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.4317858815193176},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3951592743396759},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.39418479800224304},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2723689675331116},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.21626600623130798},{"id":"https://openalex.org/C2909962599","wikidata":"https://www.wikidata.org/wiki/Q180664","display_name":"Lymphoblastic Leukemia","level":3,"score":0.14557096362113953}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000076962","descriptor_name":"Receptors, Chimeric Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054198","descriptor_name":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1177/1060028017736539","doi":"https://doi.org/10.1177/1060028017736539","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1060028017736539","pdf_url":null,"source":{"id":"https://openalex.org/S113426163","display_name":"Annals of Pharmacotherapy","issn_l":"0012-6578","issn":["0012-6578","1060-0280","1542-6270"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:29025266","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29025266","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Annals of pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W36881043","https://openalex.org/W125103739","https://openalex.org/W1488000644","https://openalex.org/W1938144043","https://openalex.org/W1948401147","https://openalex.org/W1964173702","https://openalex.org/W1967512987","https://openalex.org/W1987913042","https://openalex.org/W1991184842","https://openalex.org/W2005002555","https://openalex.org/W2016833582","https://openalex.org/W2017838975","https://openalex.org/W2031089532","https://openalex.org/W2037690521","https://openalex.org/W2043873747","https://openalex.org/W2047216756","https://openalex.org/W2056994982","https://openalex.org/W2066823421","https://openalex.org/W2070404798","https://openalex.org/W2076560655","https://openalex.org/W2082708772","https://openalex.org/W2083001039","https://openalex.org/W2107685938","https://openalex.org/W2107925822","https://openalex.org/W2109687784","https://openalex.org/W2110993734","https://openalex.org/W2113426218","https://openalex.org/W2122725450","https://openalex.org/W2123755151","https://openalex.org/W2127742735","https://openalex.org/W2128491464","https://openalex.org/W2128853862","https://openalex.org/W2141410122","https://openalex.org/W2158803162","https://openalex.org/W2320271779","https://openalex.org/W2335984750","https://openalex.org/W2340862784","https://openalex.org/W2408097265","https://openalex.org/W2416430600","https://openalex.org/W2419639370","https://openalex.org/W2520695016","https://openalex.org/W2570618306","https://openalex.org/W2582784681","https://openalex.org/W2591566159","https://openalex.org/W2591709377","https://openalex.org/W2599899418","https://openalex.org/W2614019261","https://openalex.org/W2717189176","https://openalex.org/W2891288072","https://openalex.org/W4239457183","https://openalex.org/W4254055155"],"related_works":["https://openalex.org/W7115774693","https://openalex.org/W7211953207","https://openalex.org/W4402258528","https://openalex.org/W2769833126","https://openalex.org/W4312620149","https://openalex.org/W2908115938","https://openalex.org/W2166899683","https://openalex.org/W4317548872","https://openalex.org/W4412402995","https://openalex.org/W2055401871"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"review":[2],"the":[3,20,47,53,63,103,118,121,173,200],"pharmacology,":[4,88],"efficacy,":[5,90],"and":[6,10,14,36,43,52,78,91,99,146,166,196,214],"safety":[7,92],"of":[8,22,34,44,50,56,87,93,105,123,128,176,181,202,219],"Food":[9],"Drug":[11],"Administration":[12],"approved":[13],"promising":[15],"immunotherapy":[16],"agents":[17],"used":[18],"in":[19,102,120,131,137],"treatment":[21,104,122,174],"acute":[23],"lymphoblastic":[24],"leukemia":[25],"(ALL).":[26],"DATA":[27,112],"SOURCES:":[28],"A":[29],"literature":[30],"search":[31],"was":[32],"performed":[33,61],"PubMed":[35],"MEDLINE":[37],"databases":[38],"(1950":[39],"to":[40,189],"July":[41],"2017)":[42],"abstracts":[45],"from":[46],"American":[48,54],"Society":[49,55],"Hematology":[51],"Clinical":[57],"Oncology.":[58],"Searches":[59],"were":[60,110],"utilizing":[62],"following":[64],"key":[65],"terms:":[66],"rituximab,":[67,94],"blinatumomab,":[68,98,164,194],"inotuzumab,":[69,97,165,195],"ofatumumab,":[70,95],"obinutuzumab,":[71,96],"Blincyto,":[72],"Rituxan,":[73],"Gazyva,":[74],"Arzerra,":[75],"CAR":[76,100,168,197],"T-cell,":[77],"chimeric":[79],"antigen":[80],"receptor":[81],"(CAR).":[82],"STUDY":[83],"SELECTION/DATA":[84],"EXTRACTION:":[85],"Studies":[86],"clinical":[89],"T-cells":[101,169],"adult":[106,138,155],"patients":[107,156,182],"with":[108,157,183],"ALL":[109],"identified.":[111],"SYNTHESIS:":[113],"Conventional":[114],"chemotherapy":[115],"has":[116],"been":[117],"mainstay":[119],"ALL,":[124],"producing":[125],"cure":[126],"rates":[127],"approximately":[129],"90%":[130],"pediatrics,":[132],"but":[133],"it":[134],"remains":[135,223],"suboptimal":[136],"patients.":[139],"As":[140],"such,":[141],"more":[142],"effective":[143],"consolidative":[144],"modalities":[145],"novel":[147],"therapies":[148,191,204,221],"for":[149,154],"relapsed/refractory":[150],"disease":[151,185],"are":[152,186,208],"needed":[153],"ALL.":[158,178],"In":[159],"recent":[160],"years,":[161],"anti-CD20":[162],"antibodies,":[163],"CD19-targeted":[167],"have":[170],"drastically":[171],"changed":[172],"landscape":[175],"B-cell":[177],"CONCLUSION:":[179],"Outcomes":[180],"relapsed":[184],"improving":[187],"thanks":[188],"new":[190],"such":[192],"as":[193],"T-cells.":[198],"Although":[199],"efficacy":[201],"these":[203,220],"is":[205],"impressive,":[206],"they":[207],"not":[209],"without":[210],"toxicity,":[211],"both":[212],"physical":[213],"financial.":[215],"The":[216],"optimal":[217],"sequencing":[218],"still":[222],"a":[224],"question.":[225]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-10-20T00:00:00"}